Summary Previous work has shown that the sequence -196 to -247 of the rat insulin I gene mediates the stimulatory effect of glucose in fetal islets. We have used adult rat and human islets to delineate the glucose-sensitive cis-element to the sequence -193 to -227. In electrophoretic mobility shift assays, a 22 bp nucleotide corresponding to the sequence -206 to -227 bound all the nuclear proteins that could be bound by the entire minienhancer sequence -196 to -247. The rat insulin I sequence -206 to -227 formed three major complexes; in contrast, the corresponding human insulin sequence formed one single band with human and rat islet nuclear extracts, corresponding to the complex C1 of the rat insulin gene. Incubation of islets with varying glucose levels resulted in a dose-dependent increase in the intensity of the C1 band, while the other nuclear complexes formed with the insulin sequence, or the AP1 and SP1 binding activities used as control, were glucose insensitive. This is thus the first demonstration of a physiologic glucose-sensitive trans-acting factor for the insulin gene, whose further study may markedly enhance our understanding of the regulation of insulin biosynthesis in normal and diabetic beta cells. Furthermore, once cloned, the introduction of this glucose sensitive factor may enable the construction of truly physiologic artificial beta cells. [Diabetologia (1994) 1A , B. Activities of rat insulin I sequences in rat insulinoma (RIN) cells and Rat-1 fibroblasts (A) and isolated cultured islets (B) transiently transfected using the lipofectin method. TK is a plasmid containing the thymidine kinase promoter fused to the CAT gene. Ins contains the entire 5' flanking region of the rat insulin I gene from -410 to + 1, 5FF-TK carries 5 copies of the sequences from -196 to -247, and 3GSE-TK contains 3 copies of the sequence -193 to -227 (GSE) respectively linked to the TK-CAT chimeric gene Non-insulin-dependent diabetes mellitus is probably a heterogeneous disorder. Although insulin resistance appears to be an integral part of the pathophysiology of the disease, some degree of insulin deficiency seems to be a necessary condition for the establishment of hyperglycaemia. Over the past three decades most of the investigative effort has been directed towards understanding the beta-cell disorders that lead to disturbed stimulus-secretion coupling, the emphasis being on the kinetic aspects of the acute insulin response to glucose stimulation [for review, see 1]. However, also the maximal secretory capacity of the pancreas is markedly reduced in NIDDM patients [2] , suggesting that total insulin production may be limited. Indeed, both autopsy material from NIDDM patients [3] , and islet extractions in some animal models of insulin resistance and diabetes such as the sand rat (Gadot et al., unpublished observation) have demonstrated varying degrees of depletion in the insulin content of the pancreas. Finally, in Wistar fatty rats that develop diabetes, insulin m R N A levels failed to augment in adaptation to obesity [4] . All the above suggest that, in addition to secretory defects, insulin synthesis may also be deficient in NIDDM, and that effort should also be directed towards understanding the mechanisms that regulate this process.
Insulin production is the raison d'Otre of the pancreatic beta cell. In the adult organism, the insulin gene is expressed exclusively in beta cells, indicating that strict cell-specific control mechanisms operate under normal conditions. Cell-specific phenotypic expression appears to be the result of complex interactions between cis-acting DNA elements and several trans-acting factors [5] [6] [7] . Cell culture studies and experiments with transgenic mice have demonstrated that the transcription of the insulin gene is controlled by specific D N A sequences located within its 5' flanking region [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . Binding of proteins to the putative regulatory sequences of the insulin gene has been extensively investigated using the gel mobility shift assay [20] [21] [22] [23] [24] [25] [26] [27] and has provided the basis for identification and cloning of some insulin trans-acting factors [28] [29] [30] [31] [32] [33] [34] . It has to be stressed, however, that the interpretation of these results is quite difficult, partly because transcriptional regulation is an extremely complex process involving a multitude of ubiquitous and partially as well as fully cell-type specific factors, but also because different types of transformed beta-cell lines were used in these studies. Thus, both transcription activating and inhibiting factors have been described [for review, see [35] [36] [37] . In the following, some of the studies performed in our laboratory are described in this context, with emphasis on the use of non-transformed beta cells and on the investigation of the glucose effect on insulin gene expression.
Cis-and trans-acting factors that convey beta-cell specificity to the insulin gene
There is ample evidence that several DNA motifs in the 5' flanking region of the rat insulin I gene are implicated in the full quantitative expression of insulin in the beta cell [35, 36] . These bind several nuclear proteins which, in some cases, interact with each other. They include factors expressed in many cells, like IEF 1/Pan-1 [28, 29] , the G A G A box binding protein Pur-1 [34] and the homeodomain protein cdx-3 [33] ; some are shared with neural cells (isl-1) [38] or hepatocytes (HNFlc~) [39, and unpublished results from our laboratory]; finally, some seem to be beta-cell specific (imx) [33] or shared with other genes like glucokinase [40] or islet amyloid polypeptide [19] .
D N A transfection into hamster insulinoma (HIT) cells has shown that beta-cell specific expression is controlled by sequences -400 bp upstream from the transcription start site of the rat insulin I gene. In addition, a short region extending between -196 and --247 (FF) was identified as a tissue specific transcrip- tional activator when linked to a heterologous promoter [14, 19] . This is also illustrated in Figure 1A where rat insulinoma (RIN) cells were transfected with chloramphenicol acetyl transferase (CAT) plasmids containing either the entire 400 bp promoter region of the rat insulin I gene linked to the reporter CAT gene (Ins-CAT), or multimers of the FF region cloned upstream of the thymidine kinase promoter (5FF-TK-CAT). High levels of CAT activity were obtained only in insulin producing cells, while the rat-1 fibroblasts failed to activate the chimeric genes containing insulin sequences (Fig.lA) . The chimeric gene containing the FF element was highly expressed in transfected fetal islets cultured in high glucose [41] . Transformed beta cells deviate markedly from normal islet cells, and fetal islets are different from mature islets in their insulin secretory activity, responding poorly to nutrients [42, 43] . These considerations motivated us to focus on normal islets of Langerhans, exploiting a novel monolayer culture system for adult rat islets developed in our laboratory [44] . Figure 1B demonstrates that we were successful in transfecting adult islets by the lipofectin method: high CAT levels were obtained in islets transfected with the insulin containing constructs, while levels were low in those transfected with the parental TK-CAT vector. However, even the full FF is not necessary to direct beta-cell specific gene expression. Thus, deletion of 20 bp from the upstream portion of FF (denominated Far element in [14 and 19] ) did not reduce significantly the intensity of the CAT signal when introduced into adult rat islet cells through the construct 3GSE-TK (Fig. 1B) .
The FF minienhancer element of the rat insulin I gene (-196 to -247) was tested for its ability to bind islet nuclear factors in gel electrophoresis mobility shift assays [45] . As shown in Figure 2A , three major complexes (C1-C3) were detected. By competition with fragments containing mutations along the minienhancer sequence, the 35 bp-long subfragment extending from -193 to -227 (R2) was found sufficient to bind these complexes; it also competed efficiently for the binding of proteins to the original 52 nucleotide-long mini-enhancer (Fig.2B) . To further characterize the specificity of binding of islet nuclear factors, a shorter sequence extending from -206 to -227 in the rat insulin I gene (designated R3) was synthesized. In gel retardation assays this sequence produced similar complexes (C1-C3) which were efficiently displaced by the longer D N A fragments (Fig. 2) .
The human insulin gene is expressed in transgenic mice in a cell-type specific manner [10, 11] , implying that similar trans-activating factors regulate the rodent and human insulin genes. Cross-species comparisons show that the region between -206 and -227 is ing nuclear extracts from a variety of tissues and cell lines with both probes we ascertained that the C1 complex is detected only in insulin-producing cells; furthermore, no other binding activity could be detected with the human sequence in any insulin nonproducing tissue or cell line tested.
The specific binding of the C1 complex by the human insulin enhancer probe suggests that this factor is expressed also in human islets. This was tested directly by preparing nuclear extracts from human islets for binding to the rat and the human sequences spanning the region from -206 to -227. As shown in Figure 4 lane 1, the rat probe formed the expected complexes with rat islet extracts, the lowest binding intensity being for C1. In contrast, only two complexes were detectable in human islet extracts, the predominant one co-migrating with the C1 complex (Fig.4, lane 3) . Again, the human sequence identified only the C1 complex in both species (Fig.4 , lanes 2 and 4). Fig. 3 . Binding of rat islet nuclear proteins to the rat I and human insulin D N A sequences. Gel retardation assays were performed using the rat (R3) and the human insulin probes with rat islet nuclear extracts. Competition was carried out using a 50-fold excess of unlabelled double stranded oligonucleotides of the rat sequence (R3) in lanes 2 and 6, or the human sequence (H) in lanes 3 and 5: From [45] , with permission highly conserved [46] . A human D N A sequence homologous to that of the -206 to -227 region of the rat insulin I gene (R3) was synthesized and tested in gel mobility shift assays. Figure 3 shows that using the human probe a single complex was detected, which co-migrated with the rat C1 complex (lane 4). In competition experiments, both the human and the rat R3 sequences displaced efficiently the complex formed with the human probe (Fig. 3, lanes 5 and 6) , while the human probe displaced only the C1 band from the rat sequences (Fig. 3, lane 3) . These results strongly suggest that a similar nuclear factor interacts in a sequence-specific manner with a conserved element in the human and rat insulin genes. By test-
Rat (R3) -227 CCTTGTTAATAATCTAATTACC -206 Human (H) -227 CCTGGTTAAGACTCTAATGACC -206

Stimulation of insulin gene expression by glucose
In pancreatic beta cells, glucose is the major regulator of insulin gene expression, of translational biosynthesis, and of release. Glucose controls the production of insulin at different levels, giving rise to a -20-fold increase in its biosynthesis in response to high hexose concentrations. Studies in rat and human islets, as well as in beta cell lines, have indicated that long-term control of insulin gene expression by glucose is effectuated by simultaneous enhancement of the transcription rate and inhibition of the degradation of proinsulin m R N A [47] [48] [49] [50] [51] [52] [53] [54] . Also in vivo, a close relationship was found between changes in blood glucose level and islet content of proinsulin m R N A [55, 56] . More recently, using the sensitive nuclear run-on analysis for measuring nascent insulin transcripts, Efrat et al. [57] could detect a 3-fold increase in the transcription of both the endogenous mouse insulin genes and the transgene in ~TC3 cells as early as 10 min after incubating islets at high glucose. Thus, it seems justified to presume that stimulation of the transcription rate is an early event in the action of glucose on insulin gene expression.
Little is known about the molecular mechanisms by which metabolic signals regulate gene expression in eukaryotes. So far, it has not been possible to demonstrate the presence of an insulin gene trans-acting factor whose D N A binding is regulated by glucose in any insulin-producing cell. Transient transfection experiments with cultured fetal rat islets revealed that the glucose effect on transcription rate is mediated by the FF cis-acting element located within the enhancer region of the rat insulin I gene [41] . We tested whether also in adult islets such a glucose effect could be demonstrated. In cultured adult rat and Identification of an islet specific glucose sensitive factor $7 Fig. 4 . Binding of nuclear factors from human islets to the DNA sequences of the rat and the human insulin genes. Probes corresponding to the rat insulin I gene between -206 and -227 (R3): lanes 1 and 3, and the corresponding human homologous region (H): lanes 2 and 4, were incubated with nuclear extracts from isolated rat (lanes i and 2) and human islets (lanes 3 and 4) . From [45] , with permission human islets transfected with a CAT construct containing the rat insulin I mini-enhancer from -196 to -247, glucose stimulated markedly the transcription rate [45] , the extent of stimulation being similar to that previously observed in fetal islets [41] . This indicates that despite major differences in the physiological responses of beta cells at different stages of development, glucose-induced insulin gene transcription is conserved in adult islets. We also verified the ability of the rat insulin 1 35 bp subfragment (R2) to confer glucose responsiveness in transfected islets. As seen m Figure 5 , the construct with three copies of R2 linked 5' to the TK-CAT chimeric gene responded as efficiently to glucose as the one containing 5 copies of FE These findings indicate that the subfragment of 35 nucleotides (R2) contains the glucose sensitive element (GSE) of the rat insulin I gene. Glucose usually induced 6-to 7-fold and 2-to 3-fold increase in CAT activity of rat and human islets, respectively, the lower response in human islets being probably due to the prolonged storage of the islets during transport.
To determine whether the glucose effect on transcription expressed itself at the level of DNA-binding proteins, rat islets were incubated for 3 h at various glucose concentrations; the nuclear proteins were extracted and tested for binding to the -206 to -227 sequences of the rat (R3) and the human (H) insulin genes. It could be demonstrated that the DNA-protein complex corresponding to the C1 band was sensitive to the glucose concentration to which the islets were exposed, i.e. there was a selective dose-dependent modulation of the C1 signal by extracellular glucose [45] . This is also illustrated in Figure 6 using the human insulin sequence as probe, which shows that the glucose effect on the C1 complex was already detected in islets incubated for 1 h in high glucose as compared to those maintained in low glucose levels (lanes 1-3). In summary, the overall intensity of the C1 band was 4-to 6-fold higher in extracts from islets incubated for 1-3 h at 20 mmol/1 glucose than those maintained at 2 mmol/1, whether the rat or the human D N A sequences were used to form the complex. Whereas the tissue-specific C1 complex was sensitive to glucose, neither the AP1 (Fig. 6, lanes 4-6) nor the SP1 binding proteins (data not shown) were affected by the glucose concentration of the islet incubate.
Mode of action of glucose on the transcriptional activation of insulin
It is generally accepted that all actions of glucose on beta cell functions require the uptake and metabolism of the sugar [for review, see 58] . Two recent studies support the idea that insulin gene expression is controlled by the glucose metabolism of the islet. Thus, Goodison et al. [59] found that in HIT cells transfected with a CAT construct containing the sequence -345 to + 1 of the rat insulin I gene the glucose effect on transcription could be entirely blocked by mannoheptulose, an inhibitor of glucose phosphorylation. While the islet substrate mannose was as effective as glucose, galactose, which is not metabolized in beta cells, did not stimulate the CAT activity. Supporting these findings, German [60] demonstrated in fetal rat islets transfected with a similar CAT construct that neither fructose nor the nonmetabolized analogue 2-deoxyglucose could substitute for glucose. Interestingly, pyruvate was inactive (as it is regarding insulin release). Thus, these results strongly suggest that early steps in beta cell glycolysis mediate the effect of glucose on the transcriptional activation of the insulin gene.
Glucose stimulation of beta cells is accompanied by a rapid increase in intracellular calcium. The glucose induction of insulin transcription was inhibited . Glucose sensitive factor in rat islet cells binds to the -206 to -227 sequence of the human insulin gene. Nuclear extracts from rat islets exposed to the indicated glucose concentrations for 1 h were incubated with the labelled human probe, as well as with the AP1 binding site, and tested using the gel mobility shift assay by calcium channel blockers in some [41, 57] but not all [59] studies. Thus, while it is attractive to postulate that glucose might utilize the beta cell calcium pathway as a common means for stimulating both the synthesis and the release of insulin, further work is necessary to clarify the mechanism by which the observed glucose effects on insulin gene expression are mediated.
Conclusions
In the present studies the cis-element of the insulin gene that acts as a glucose sensitive element has been delineated with greater precision in rat as well as human islets, and a putative nuclear factor for the glucose effect described. It is clear from these results that treatment of islets with high glucose did not cause the formation of a new D N A binding complex, but rather elicited a rapid change in the binding intensity of the C1 complex. These changes in binding correspond to the overall increase in insulin m R N A level following rise in extracellular glucose in different systems [22, [30] [31] [32] , as well as to the increase in CAT activity in transfected islet cells as shown here (Fig. 5 ) and elsewhere [41] . We suggest the term of glucose sensitive factor (GSF) for the protein(s) involved in the C1 complex. This is the first demonstration of a physiologic glucose-sensitive trans-acting factor for the insulin gene, and we expect that further studies on the mode of action of glucose sensitive factor may greatly enhance our understanding of the regulation of insulin biosynthesis in normal and diabetic islets.
The long-term goal for diabetes therapy is development of a genetically engineered "beta cell" capable of secreting insulin in response to glucose under physiological conditions. The genetic engineering of the AtT20 pituitary cell by Hughes et al. [61] has helped to move forward towards such a goal, although their "'artificial beta cell" secretes insulin in response to dbcAMP but not to glucose. We believe that the introduction of the glucose sensitive factor described here to such a system could allow the regulation of insulin production by glucose.
